Non-invasive Glucose Monitoring via Multi-frequency Tissue Conductometry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current non-invasive methods for estimating blood glucose levels, such as impedance spectroscopy, are unreliable and costly, as they are influenced by factors other than glucose concentration, like tissue hydration, leading to a lack of affordable and effective glucometers.

Innovation Solution

A non-invasive conductometry method that measures the variation in the volume of interstitial fluid compartments in muscular tissue due to osmotic pressure changes correlated with glucose levels, using tetrapolar electrodes and alternating currents to differentiate between changes caused by glucose and vessel volume, with temperature correction for accurate glucose level estimation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If impedance spectroscopy or conductometry methods are used for non-invasive glucose estimation, then the device cost is reduced and accessibility is improved, but the measurement reliability deteriorates due to interference from tissue hydration and other physiological factors

Engineering Contradiction:
Improvedevice costVSAvoidmeasurement reliability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The measurement is segmented into two distinct frequency components: a first frequency component sensitive to extracellular fluid (ECF) volume changes and a second frequency component sensitive to total tissue water content. By separating these measurements, the system can isolate glucose-related ECF changes from general hydration changes, thereby maintaining measurement reliability while using affordable conductometry hardware.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system changes the measurement parameter from single-frequency impedance to multi-frequency conductometry, measuring at both a first frequency (e.g., 10-100 kHz) and a second frequency (e.g., 1-10 MHz). This parameter change allows differentiation between ECF volume changes (glucose-related) and total water content changes (hydration-related), resolving the reliability issue while keeping the device low-cost.

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If single-frequency impedance measurement is used, then the device complexity is reduced, but the ability to differentiate between glucose-induced changes and vessel volume changes deteriorates

Engineering Contradiction:
Improvedevice complexityVSAvoidglucose level estimation precision
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The measurement process is segmented into multiple frequency components, each probing different tissue compartments. The first frequency component primarily reflects ECF volume changes, while the second frequency component reflects total tissue water. This segmentation enables the system to distinguish glucose-induced ECF changes from other fluid shifts without requiring complex additional sensors.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system applies a form of partial action by selectively using frequency-specific conductivity measurements to extract only the ECF volume component relevant to glucose monitoring, rather than attempting to measure all tissue properties. This selective approach maintains reasonable device complexity while achieving the necessary measurement precision.

Inventive Principle:
Principle #16Partial or excessive action

3Productivity

If conventional impedance methods are used, then the measurement speed is sufficient, but the accuracy deteriorates due to sensitivity to extracellular fluid variations and electrode contact issues

Engineering Contradiction:
Improvemeasurement speedVSAvoidaccuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The system changes from single-frequency impedance measurement to multi-frequency conductometry, measuring conductivity at both a first frequency (sensitive to ECF) and a second frequency (sensitive to total water). By processing both frequency components and comparing their ratio or difference, the system eliminates sensitivity to electrode contact variations and general hydration changes, thereby improving accuracy while maintaining rapid measurement capability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides reliable, low-cost estimation of blood glucose level variations with high accuracy, capable of detecting changes within seconds, and is less sensitive to extracellular fluid variations and electrode contact issues, offering a more precise glucose monitoring solution.

Implementation Method 1

The conductivity measurements are carried out at least with an alternating current having a relatively low frequency

Methodology Applied
Scientific EffectElectrical Conductivity: Conduction (electrical)

Implementation Method 2

the variation of the volume of the interstitial fluid compartments in muscular tissue due to a shift of fluid between the extracellular and intracellular compartments caused by variations of the osmotic pressure of the extracellular fluids

Methodology Applied
Scientific EffectOsmotic Pressure: Osmotic Pressure

Data Source

PatentUS8886274B2Non-invasive method for estimating of the variation of the glucose level in the blood of a person and apparatus for carrying out the method
Publication Date: 2014.11.11 GERINOVA
  • US8886274B2 patent drawing
  • US8886274B2 patent drawing
  • US8886274B2 patent drawing

AI summary

The estimation of the variation of the glucose level in the blood of a person by the variation of the volume of the interstitial fluid compartments in muscular tissue due to a shift of fluid between the extracellular and intracellular compartments caused by variations of the osmotic pressure of the extracellular fluids which is in turn correlated with the glucose level. The variation of the volume of the interstitial fluid compartments is detected by a non-invasive conductometry measurement using electrodes placed in contact with the skin of the person overlying a portion of soft tissue including muscular fibers. To eliminate the adverse effect of the conductivity of the capillary vessels, the conductivity of the tissue is measured independently in two directions, namely parallel and transverse to the muscular fibers.